Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

The Big Market Report Take

Hims & Hers Health’s plan to enter the business of selling peptides is looking a lot more realistic.

Read full article on MarketWatch Follow on X Follow on Bluesky Back to today's briefing

Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →

Never miss a story

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

More from this section